Dysfunction or aberrant expression of AID can lead to several immunological disorders. For instance, insufficient AID activity can result in hyper-IgM syndrome, where B cells are unable to undergo class switch recombination, leading to an overproduction of IgM antibodies. Conversely, overexpression or improper regulation of AID can cause genomic instability, contributing to the development of B cell lymphomas and other cancers.
